• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质乳剂中皮质类固醇的组织分布及抗炎活性

Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion.

作者信息

Mizushima Y, Hamano T, Yokoyama K

出版信息

Ann Rheum Dis. 1982 Jun;41(3):263-7. doi: 10.1136/ard.41.3.263.

DOI:10.1136/ard.41.3.263
PMID:6896429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1000924/
Abstract

Dexamethasone palmitate was incorporated into a lipid emulsion (Intralipid, Intralipos) and was injected into rats, and its distribution in the organs and tissues and its anti-inflammatory effects were compared with those of free dexamethasone disodium phosphate. The distribution patterns of [3H] dexamethasone were markedly different between the 2 preparations in 3 hours after intravenous administration. Dexamethasone palmitate given as a lipid emulsion showed a much higher concentration in the blood, spleen, and inflamed tissues (carrageenan oedema), whereas dexamethasone sodium phosphate had a high concentration in the muscles. The anti-inflammatory activity of both preparations given intravenously was evaluated by using the preformed carrageenan granuloma pouch method. The anti-inflammatory activity of lipid emulsion dexamethasone was 5.6 times as potent as an equivalent amount of free dexamethasone. These results may indicate that corticosteroids which are incorporated in lipid emulsions are taken up by the reticuloendothelial system and some inflammatory cells much more than are free corticosteroids; thus they have a stronger anti-inflammatory activity. The clinical use of lipid emulsion corticosteroids for certain types of diseases is suggested.

摘要

将地塞米松棕榈酸酯加入脂质乳剂(英脱利匹特,脂肪乳)中并注射到大鼠体内,将其在器官和组织中的分布及其抗炎作用与游离地塞米松磷酸二钠进行比较。静脉给药3小时后,两种制剂中[3H]地塞米松的分布模式明显不同。以脂质乳剂形式给予的地塞米松棕榈酸酯在血液、脾脏和炎症组织(角叉菜胶性水肿)中的浓度要高得多,而地塞米松磷酸钠在肌肉中的浓度较高。通过使用预先形成的角叉菜胶肉芽肿袋法评估静脉给予的两种制剂的抗炎活性。脂质乳剂地塞米松的抗炎活性是等量游离地塞米松的5.6倍。这些结果可能表明,加入脂质乳剂中的皮质类固醇比游离皮质类固醇更多地被网状内皮系统和一些炎症细胞摄取;因此它们具有更强的抗炎活性。建议脂质乳剂皮质类固醇用于某些类型疾病的临床治疗。

相似文献

1
Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion.脂质乳剂中皮质类固醇的组织分布及抗炎活性
Ann Rheum Dis. 1982 Jun;41(3):263-7. doi: 10.1136/ard.41.3.263.
2
Development of a corticosteroid incorporated in lipid microspheres (liposteroid).脂质微球包裹的皮质类固醇(脂皮质类固醇)的研发。
Drugs Exp Clin Res. 1985;11(9):611-20.
3
A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.一种纳米脂质乳剂,脂质纳米球(LNS),作为用于被动药物靶向的肠外药物载体。
Int J Pharm. 2004 Apr 1;273(1-2):75-83. doi: 10.1016/j.ijpharm.2003.12.022.
4
Effects of liposteroid on skin lesions in autoimmune MRLlpr/lpr mice.
J Dermatol Sci. 1997 Nov;16(1):45-51. doi: 10.1016/s0923-1811(97)00620-8.
5
Therapeutic effects on intestinal Behçet's disease of an intravenous drug delivery system using dexamethasone incorporated in lipid emulsion.
J Gastroenterol Hepatol. 2001 Nov;16(11):1306-8. doi: 10.1046/j.1440-1746.2001.02510.x.
6
Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.载注射用醋酸地塞米松的纳米结构脂质载体的抗炎活性。
Drug Deliv. 2011 Sep-Oct;18(7):485-92. doi: 10.3109/10717544.2011.589087. Epub 2011 Jun 22.
7
Blood clearance kinetics and organ delivery of medium-chain triglyceride and fish oil-containing lipid emulsions: Comparing different animal species.中链甘油三酯和含鱼油的脂肪乳剂的血液清除动力学和器官递送:比较不同的动物物种。
Clin Nutr. 2021 Mar;40(3):987-996. doi: 10.1016/j.clnu.2020.07.002. Epub 2020 Jul 14.
8
Use of a lipid emulsion as a novel carrier for corticosteroids.使用脂质乳剂作为皮质类固醇的新型载体。
J Pharm Pharmacol. 1982 Jan;34(1):49-50. doi: 10.1111/j.2042-7158.1982.tb04678.x.
9
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.盐酸罗哌卡因注射用乳剂与静脉注射盐酸帕洛诺司琼注射液和地塞米松磷酸钠注射液混合后的相容性和稳定性。
Int J Pharm Compd. 2018 Jan-Feb;22(1):76-85.
10
Serum concentrations, pharmacokinetic/pharmacodynamic modeling, and effects of dexamethasone on inflammatory mediators following intravenous and oral administration to exercised horses.静脉注射和口服给予运动马匹后,地塞米松的血清浓度、药代动力学/药效学模型以及对炎症介质的影响。
Drug Test Anal. 2020 Aug;12(8):1087-1101. doi: 10.1002/dta.2862. Epub 2020 Jun 22.

引用本文的文献

1
Rationale and design for the thoracic Paravertebral Adjunctive Dexamethasone Palmitate Reducing chronic pain After cardiac surgery (PANDORA) trial: a parallel-group, double-blinded, randomised controlled, single-centre study.心脏手术后胸椎旁辅助使用棕榈酸地塞米松减轻慢性疼痛(PANDORA)试验的原理与设计:一项平行组、双盲、随机对照、单中心研究。
BMJ Open. 2025 Jan 15;15(1):e086392. doi: 10.1136/bmjopen-2024-086392.
2
Dexamethasone palmitate for children with Epstein-Barr virus associated hemophagocytic lymphohistiocytosis.棕榈酸地塞米松用于治疗儿童 Epstein-Barr 病毒相关噬血细胞性淋巴组织细胞增生症。
Int J Hematol. 2025 Feb;121(2):252-256. doi: 10.1007/s12185-024-03892-z. Epub 2024 Dec 4.
3
Evaluation of Gemcitabine and Epigallocatechin-3-Gallate Loaded Solid Lipid Nanoparticles on Benzopyrene Induced Lung Cancer Model Via Intranasal Route: Improved Pharmacokinetics and Safety Profile.经鼻途径给予吉西他滨和表没食子儿茶素-3-没食子酸酯负载的固体脂质纳米粒对苯并芘诱导的肺癌模型的评价:改善的药代动力学和安全性概况。
AAPS PharmSciTech. 2024 Jul 31;25(6):176. doi: 10.1208/s12249-024-02892-w.
4
Glucocorticoids-based prodrug design: Current strategies and research progress.基于糖皮质激素的前药设计:当前策略与研究进展
Asian J Pharm Sci. 2024 Jun;19(3):100922. doi: 10.1016/j.ajps.2024.100922. Epub 2024 Apr 24.
5
Dexamethasone palmitate as an etoposide-free treatment for children with hemophagocytic lymphohistiocytosis after hematopoietic cell transplantation.棕榈酸地塞米松作为造血细胞移植后噬血细胞性淋巴组织细胞增生症患儿的无依托泊苷治疗方案。
Bone Marrow Transplant. 2023 Nov;58(11):1286-1288. doi: 10.1038/s41409-023-02098-x. Epub 2023 Aug 29.
6
Preparation and evaluation of an intravenous emulsion loaded with an aprepitant-phospholipid complex.载阿瑞匹坦-磷脂复合物的静脉乳剂的制备与评价。
Drug Deliv. 2023 Dec;30(1):2183834. doi: 10.1080/10717544.2023.2183834.
7
Pre-incisional infiltration with ropivacaine plus dexamethasone palmitate emulsion for postoperative pain in patients undergoing craniotomy: study protocol for a prospective, randomized controlled trial.罗哌卡因联合棕榈酸地塞米松预切口浸润用于开颅术后疼痛患者:一项前瞻性、随机对照试验的研究方案。
Trials. 2022 Dec 12;23(1):996. doi: 10.1186/s13063-022-06936-z.
8
Signal properties of split-spectrum amplitude decorrelation angiography for quantitative optical coherence tomography-based velocimetry.基于定量光学相干断层扫描测速技术的分裂谱幅度去相关血管造影术的信号特性
Biomed Opt Express. 2021 Sep 2;12(10):5955-5968. doi: 10.1364/BOE.432297. eCollection 2021 Oct 1.
9
Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.系统性红斑狼疮活动诱发的巨噬细胞活化综合征:地塞米松磷酸钠、静脉注射用免疫球蛋白和环孢素联合治疗成功:一例报告。
J Med Case Rep. 2021 Oct 7;15(1):497. doi: 10.1186/s13256-021-03072-1.
10
Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions.特发性肺含铁血黄素沉着症:对过去 30 年使用的治疗方法的回顾及未来方向。
Clin Rheumatol. 2021 Jul;40(7):2547-2557. doi: 10.1007/s10067-020-05507-4. Epub 2020 Nov 12.

本文引用的文献

1
Diminished bacterial defences with intralipid.脂肪乳剂导致细菌防御能力下降。
Lancet. 1980 Oct 18;2(8199):819-20. doi: 10.1016/s0140-6736(80)90171-3.
2
Hepatic "intravenous fat pigment" in infants and children receiving lipid emulsion.接受脂质乳剂的婴幼儿肝脏中的“静脉脂肪色素”
J Pediatr Surg. 1975 Oct;10(5):641-8. doi: 10.1016/0022-3468(75)90367-x.
3
Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis.脂质体包裹的皮质类固醇。II. 对实验性关节炎的治疗活性
Ann Rheum Dis. 1979 Dec;38(6):553-7. doi: 10.1136/ard.38.6.553.
4
Liposome-incorporated corticosteroids: I. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane.
Br J Exp Pathol. 1979 Apr;60(2):142-50.
5
Liposomes as drug carriers.脂质体作为药物载体。
Life Sci. 1977 Apr 1;20(7):1109-20. doi: 10.1016/0024-3205(77)90481-7.
6
Liposomes in arthritis: a new approach.
Lancet. 1979 Jun 23;1(8130):1320-2. doi: 10.1016/s0140-6736(79)91951-2.